Waters' Next-Generation Synapt and Thermo Fisher's Velos Line Lead New MS Launches at ASMS | GenomeWeb

This story originally ran on June 2.

PHILADELPHIA – While a number of vendors used this year's American Society for Mass Spectrometry annual conference to showcase instruments launched earlier in the year, Waters and Thermo Fisher Scientific were the only vendors to launch new mass specs at the meeting held here this week.

Five years after the launch of its Synapt HDMS platform, Waters on Monday launched the next generation of its flagship mass spectrometer, the Synapt G2, while Thermo introduced its LTQ Velos and LTQ Orbitrap Velos.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.